Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
66,164,282
-
Share change
-
+1,125,491
-
Total reported value
-
$6,287,538,119
-
Put/Call ratio
-
358%
-
Price per share
-
$95.11
-
Number of holders
-
466
-
Value change
-
+$141,039,047
-
Number of buys
-
188
-
Number of sells
-
185
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2019
As of 31 Dec 2019,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
466 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,164,282 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, CITIGROUP INC, MORGAN STANLEY, BANK OF NOVA SCOTIA, BANK OF AMERICA CORP /DE/, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, BARCLAYS PLC, WELLS FARGO & COMPANY/MN, UBS Group AG, and NATIXIS.
This page lists
469
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.